Clinical trials
Phase 2 Hyperkalemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 5 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Relypsa, Inc. | 5 |
| Ardelyx | 2 |
| AstraZeneca | 2 |
| Vifor Pharma, Inc. | 2 |
| Barts & The London NHS Trust | 1 |
| Dominic Raj | 1 |
| Michael Fu | 1 |
| Waterstone Pharmaceutical (Wuhan) Co., LTD. | 1 |
| ZS Pharma, Inc. | 1 |
| Zeria Pharmaceutical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperkalemia | 17 |
| Renal Insufficiency, Chronic | 6 |
| Heart Failure | 4 |
| Hypertension | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Diabetic Nephropathies | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.